This is a firm fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH), to Illumina, Inc. for maintenance and repair services of Illumina's NovaSeq 6000 sequencing equipment. The contract has a ceiling value of $43,380.00 and a period of performance ending on October 12, 2025. The contract was awarded on a sole-source basis, as Illumina is the original equipment manufacturer of the NovaSeq 6000 sequencer....
This is a firm fixed price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Aging to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions. The $91,872.00 contract is for maintenance and repair services for Illumina laboratory equipment used by the agency, with a completion date of June 10, 2027. Illumina has provided sequencing systems and associated products and services to support genomic...
This is a firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH), to Illumina, Inc. for maintenance and repair services for Illumina laboratory equipment, including Tecan LIHA, iScan, and Autoloader instruments. The $81,246.86 contract has a base period of performance from August 16, 2021 to December 16, 2021, with an option to extend through December 16, 2022. There were no set-aside requirements for this...
This firm fixed-price purchase order was awarded by the National Institute on Aging, a civilian agency, to Illumina, Inc. for maintenance and repair support of three Illumina laboratory instruments used for genomic analysis and sequencing. The $205,890.00 contract covers support for the Illumina AutoLoader 2.x, LIHA 1, and iScan systems through December 16, 2025. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, and has provided a range of...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc. for an Illumina Service Contract. The contract has a ceiling value of $72,973.00 and a period of performance through February 28, 2026. Illumina, a manufacturer of genomic sequencing and analysis instruments and reagents, will provide maintenance and support services for NIAID's Illumina sequencing systems, including NextSeq,...
This firm fixed-price purchase order was awarded by the National Institute on Aging (NIA), a civilian agency, to Illumina, Inc. for the provision of an Illumina iSeq 100 Sequencing System. The total ceiling value of the contract is $20,198.50, with a period of performance ending on January 17, 2025. The award was not set aside for any specific socioeconomic category. Illumina is a manufacturer of a range of genomic sequencing instruments and analytical products that have been utilized across...
This is a firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian agency, to Illumina, Inc. for maintenance and repair services for a microarray system and Tecan robotic liquid handling apparatus. The $48,251.40 contract has an ultimate completion date of August 31, 2023. The purchase was not set aside for any socioeconomic program. Illumina is a manufacturer of sequencing and array-based solutions for genomic analysis, and has previously provided a range...
This is a $189,332.15 firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis instruments and reagents. The contract provides an annual service agreement for four Illumina sequencing instruments, including preventative maintenance, parts, labor, reagent replacement, and technical...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genomic analysis technologies. The $249,519.59 contract is for a service agreement to provide multiple Illumina DNA sequencers over a 1-year period from August 28, 2025 to August 27, 2026. The contract does not utilize a set-aside designation. Illumina is a...
This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. for a maintenance service contract on various Illumina sequencing instruments. The contract has a period of performance from November 30, 2015 to November 29, 2016, with four one-year option periods, for a total potential value of $128,638. The contract does not have a set-aside designation....
This is a firm fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency, to Illumina, Inc. for maintenance and repair services for Illumina laboratory equipment, specifically the iScan system. The contract has a ceiling value of $178,375.00 and a period of performance from May 18, 2022, to May 1, 2025, with up to four one-year option periods. The contract was not set aside for any small business designations.
Illumina, Inc. is a leading manufacturer of genetic sequencing and genomic analysis technologies. The company has been awarded numerous prime federal contracts and grants across agencies such as the NIH, CDC, USDA, VA, and FDA, primarily for the procurement of Illumina's advanced sequencing instruments, reagents, and related services. This contract supports the NIA's research initiatives at the Center for Alzheimer's Disease and Related Dementias, ensuring the continued functionality of the iScan equipment used in their work.